Literature DB >> 1855468

Opposing effects of retinoic acid and dexamethasone on cellular retinol-binding protein ribonucleic acid levels in the rat.

M G Rush1, R Ul-Haq, F Chytil.   

Abstract

Cellular retinol-binding protein (CRBP) is a potential mediator of vitamin A action. To determine whether retinoic acid and dexamethasone administration, alone and in combination, influence CRBP gene expression, adult female vitamin A-sufficient Sprague-Dawley rats randomly received 1) all-trans retinoic acid (100 micrograms) by intragastric intubation, 2) dexamethasone (2 micrograms/g BW) by ip injection, or 3) both all-trans retinoic acid and dexamethasone in the same doses. Control animals received either cottonseed oil by intragastric intubation or saline by ip injection. Six hours after treatment, lung and liver tissue were collected for Northern blot analysis with the radiolabeled cDNA specific for rat CRBP. Retinoic acid administration increased the amount of lung CRBP mRNA only, whereas dexamethasone decreased both lung and liver CRBP mRNA abundance. In animals treated with both retinoic acid and dexamethasone, CRBP mRNA abundance was also reduced. We conclude that CRBP gene expression can be modulated by both retinoic acid and dexamethasone in the vitamin A-sufficient animal. In the whole animal, our findings indicate that dexamethasone not only represses CRBP gene expression, but also opposes the effect of retinoic acid.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855468     DOI: 10.1210/endo-129-2-705

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

1.  Human NCU-G1 can function as a transcription factor and as a nuclear receptor co-activator.

Authors:  Knut R Steffensen; Mariam Bouzga; Frode Skjeldal; Cecilie Kasi; Almira Karahasan; Vilborg Matre; Oddmund Bakke; Sylvain Guérin; Winnie Eskild
Journal:  BMC Mol Biol       Date:  2007-11-16       Impact factor: 2.946

2.  Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer.

Authors:  Alice Arapshian; Silvina Bertran; Yuvarani S Kuppumbatti; Shigeo Nakajo; Rafael Mira-y-Lopez
Journal:  Mol Cancer       Date:  2004-04-27       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.